Camber Pharmaceuticals Inc recalls Losartan Potassium Tablets USP, 50 mg, Rx only, a) 30 count (NDC 31722-701-30), b) 90 count (NDC 31722-701-90), c) 1000
Camber Pharmaceuticals recalls 50mg Losartan Potassium Tablets due to trace amounts of NMBA detected in the active ingredient. This may pose a contamination risk during medication use.
Lower-risk recall
CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient
Contact the company & request your remedy
What happened, in plain English
Camber Pharmaceuticals is recalling certain 50mg Losartan Potassium Tablets because trace amounts of a chemical called NMBA were found in the active ingredient. This could potentially cause contamination risks when taken as medication. Read more at govinfonow.com/recall/39141-camber-pharmaceuticals-losartan-tablets-recall-trace-nmba-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39141-camber-pharmaceuticals-losartan-tablets-recall-trace-nmba-contamination-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1042-2019
Cite this page
“Camber Pharmaceuticals Losartan Tablets Recall: Trace NMBA Contamination Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39141-camber-pharmaceuticals-losartan-tablets-recall-trace-nmba-contamination-risk. Based on FDA recall #D-1042-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1042-2019%22&limit=1).
Why it’s dangerous
The recall is due to trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) being detected in the active pharmaceutical ingredient. This chemical is not typically present in medications and could potentially cause contamination risks when taken as medication.
Who’s affected
People who have prescription Losartan Potassium Tablets from Camber Pharmaceuticals, specifically those with the 30-count, 90-count, or 1000-count bottles with the listed NDC numbers. Those taking blood pressure medication are most at risk.
How to tell if you have this one
Check your prescription bottles for the NDC numbers: 31722-701-30 (30 count), 31722-701-90 (90 count), or 31722-701-1000 (1000 count). The bottles were manufactured by Hetero Labs Limited in India with specific expiration dates listed in the recall notice.
- Brand
Camber Pharmaceuticals- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Nationwide- NDC
31722-700-30, 31722-700-60, 31722-700-90, 31722-700-05, 31722-700-10, 31722-701-30, 31722-701-60, 31722-701-90, 31722-701-05, 31722-701-10, 31722-702-30, 31722-702-60, 31722-702-90, 31722-702-05, 31722-702-10
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1041-2019 | Losartan Potassium Tablets USP, 25 mg, Rx only, a) 90 count (NDC 31722-700-90), b) 500 count (NDC 31722-700-05) and c) 1000 count (NDC 31722-700-05) bottles, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar -509 301, India; a) LOP17026B, LOP17050, LOP1705, LOP17052, LOP17053, Exp. Sep-19; LOP17061, Exp. Oct-19; LOP18035, LOP18036, Exp. Dec-19; b) LOP17026, Exp. Sep-19; c) LOP17006, Exp. May-19, LOP17025, Exp. Sep-19, LOP17068, Exp, Oct-19, LOP18037, LOP18038, LOP18039, Exp. Dec-19, LOP18057, Exp. Jan-20 | 351,732 bottles |
| D-1042-2019 | Losartan Potassium Tablets USP, 50 mg, Rx only, a) 30 count (NDC 31722-701-30), b) 90 count (NDC 31722-701-90), c) 1000 count (NDC 31722-701-10) bottles, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar -509 301, India; a) LOP17028C, Exp. Sep-19, LOP17064A, Exp. Nov-19; b) LOP17027, Exp Sep-19, LOP17063, LOP17093, Exp. Nov-19; LOP17094, LOP17095, LOP17097A, LOP17105, LOP17107, Exp. Dec-19; c) LOP17004, Exp Dec-19, LOP17028B, Exp Sep-19, LOP17048, LOP17049 Exp Oct-19, LOP17056, LOP17073, LOP17074, LOP17076 Exp Nov-19, LOP17096, Exp Dec-19, LOP18077A, LOP18078, LOP18079, LOP18080 Exp Feb-20; LOP18081, LOP18084, LOP18095, LOP18096 Exp Mar-20 | 69712 bottles |
| D-1043-2019 | Losartan Potassium Tablets USP, 100 mg, Rx only, a) 30 count (NDC 31722-702-30), b) 90 count (NDC 31722-702-30), c) 1000 count (NDC 31722-702-10) bottles, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar -509 301, India; a) LOP17011, Exp Aug-19, Lot LOP17087 Exp Nov-19; b) LOP17012, LOP17013, Exp Aug-19, LOP17042, LOP17043 Exp Oct-19, LOP17044, LOP17045, Exp Nov-19, LOP18024, LOP18025, LOP18026, LOP18027, LOP18028, LOP18029, LOP18030, Exp. Dec-19; c) LOP17005, Exp May-19, LOP17014, Exp Aug-19, LOP17016, LOP17023, Exp Sep-19, LOP17083, Exp Oct-19, LOP17084, LOP17085, LOP17086, Exp Nov-19, LOP18021, LOP18022, LOP18023, LOP18031, LOP18032, LOP18033, LOP18050, LOP18051, Exp Dec-19, LOP18109, LOP18111, Exp Mar-20, LOP18122, LOP18123, LOP18124, LOP18125, LOP18126, LOP18127, LOP18128, LOP18129, LOP18130, LOP18131C, LOP18133, Exp Jun-20 | 683,641 bottles |
What to do — step by step
Check Your Medication
Look for the NDC numbers 31722-701-30, 31722-701-90, or 31722-701-1000 on your prescription bottle.
Questions people ask
Why is this medication being recalled?
Camber Pharmaceuticals detected trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) in the active pharmaceutical ingredient.
What should I do if I have these tablets?
The recall notice does not specify a remedy, so you should check with your healthcare provider or pharmacist for guidance.
Are there any specific expiration dates I should watch for?
The recall includes specific expiration dates for each batch, but the notice does not provide a general expiration date for all affected products.
Contact Camber Pharmaceuticals
We’ve drafted a message you can send Camber Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1042-2019 — Camber Pharmaceuticals Camber Pharmaceuticals Hello, I own a Camber Pharmaceuticals that is covered by recall D-1042-2019 from Camber Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1042-2019 (February 28, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1042-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.